Autoimmune Hepatitis in Children: The Current State of the Problem by G. V. Volynets, A. I. Khavkin, T. A. Skvortsova, V. V. Matkash

“…In cases of refractoriness to therapy and the disease progression to liver cirrhosis and its decompensation, liver transplantation is justified. It is shown that AIH might relapse after liver transplantation. …”
Get full text

Potential of albumin dialysis at terminal liver failure in patients with chronic liver diseases by O. E. Nikiforova, Ye. N. Bessonova, O. M. Lesnyak, O. A. Stroganova

“…Albumin dialysis in the patients with cirrhosis enrolled to the waiting list of liver transplantation, allows to prolong scheduled interim to liver transplantation that is the extremely important factor, allowing to survive to operation and to decrease mortality in patients with terminal liver failure.…”
Get full text

Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control by Yun Gao, Xiushan Yin, Xiaomeng Ren

“…Up to now, the most effective treatment for end-stage liver diseases is liver transplantation. However, liver transplantation has the problems of donor deficiency, low matching rate, surgical complications, high cost, and immune rejection. …”
Get full text

The Role of Bridging Therapy in Hepatocellular Carcinoma by Roberto Galuppo, Angie McCall, Roberto Gedaly

“…For that reason, liver resection is only possible in selected patients. Liver transplantation has become the treatment of choice in patients with HCC, end-stage liver disease, and significant portal hypertension. …”
Get full text

An Unusual Occurrence of Hepatic Granulomas and Secondary Sitosterolemia in Turner Syndrome by JayaKrishna Chintanaboina, Pragnesh R. Shah, Thomas R. Riley

“…Of the three patients, first patient underwent liver transplantation; second patient remained stable on immunosuppressants; and third patient died from complications of decompensated liver cirrhosis as she declined liver transplantation due to multiple comorbidities. …”
Get full text

Update on Primary Biliary Cirrhosis by Jenny Heathcote

“…Treatment at a dose of 13 to 15 mg/kg/day is optimal, given in separate doses or as a single dose at least 4 h from giving the oral anion exchange resin cholestyramine, which may be used to control pruritus. However, liver transplantation remains the only cure for this disease, and the best postoperative survival is seen in patients whose serum bilirubin does not exceed 180 µmol/L at the time of liver transplantation. …”
Get full text

Spontaneous Clearance of Hepatitis C after Liver and Renal Transplantation by CH Dale, P Burns, M McCutcheon, R Hernandez-Alejandro, PJ Marotta

“…It has been recognized that patients receiving liver transplantation for HCV-related disease have decreased graft and patient survival compared with those transplanted for other etiologies. …”
Get full text

Management of Acute Wilsonian Hepatitis with Severe Hemolysis: A Successful Combination of Chelation and MARS Dialysis by Jeremy Hassoun, Nathalie Hammer, Giulia Magini, Belen Ponte, Marie Ongaro, Anne-Laure Rougemont, Nicolas Goossens, Jean-Louis Frossard, Laurent Spahr

“…The early initiation of a combined treatment including conventional chelation therapy and repeated MARS dialysis sessions allowed a rapid control of hemolysis, a progressive decrease of free copper overload, and clinical recompensation without liver transplantation.…”
Get full text

Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age by Marco Gasparetto, Graziella Guariso

Get full text

Systemic Venous Inflow to the Liver Allograft to Overcome Diffuse Splanchnic Venous Thrombosis by Cristian Lupascu, Tom Darius, Pierre Goffette, Jan Lerut

“…Diffuse splanchnic venous thrombosis (DSVT), formerly defined as contraindication for liver transplantation (LT), is a serious challenge to the liver transplant surgeon. …”
Get full text

Radical Resection of a Late-Relapsed Testicular Germ Cell Tumour: Hepatectomy, Cavotomy, and Thrombectomy by C. Ní Leidhin, C. E. Redmond, A. M. Cahalane, H. M. Heneghan, R. Motyer, E. R. Ryan, E. Hoti

“…Techniques practised in liver transplantation were used to achieve complete resection of the tumour thrombus. …”
Get full text

A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma by Vlad Herlea, Elena Stoica Mustafa, Andreea Cristina Iorgescu, Nicolae Catalin Pechianu, Dragos Cretoiu, Maria Sajin, Simona Olimpia Dima, Catalin Vasilescu, Cezar Stroescu, Constantin Ungureanu, Traian Dumitrascu, Vladislav Brasoveanu, Minerva Ghinescu, Irinel Popescu

Get full text

Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation by Yur-Ren Kuo, Chien-Chang Chen, Shigeru Goto, Pao-Yuan Lin, Fu-Chan Wei, Chao-Long Chen

Get full text

The Role of Monocyte/Macrophage and CXCR3 in Differentiation between Recurrent Hepatitis C and Acute Cellular Rejection Postliver Transplantation by Asmaa Ibrahim Gomaa, Nermine Ahmed Ehsan, Ahmed A. Elrefaei, Mervat Mohamed Sultan, Maha Mohamed Elsabaawy

“…Objective. Liver transplantation (LT) is the recommended treatment for patients with advanced liver disease and cirrhosis in all guidelines, mostly as a complication of HCV. …”
Get full text

The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis by Youmin Pan, Renyong Guo, Yan Lv, Dawei Cui, Jue Xie

“…Patients who died or underwent liver transplantation had elevated levels of MELD and vWF-Ag. …”
Get full text

Heparanase, A Key Target for Gene Therapy against Human Malignancies by Youlei Zhang, Yi Wang, Zhiren Fu, Feng Shen

Get full text

Diagnostic Accuracy of Lipase as Early Predictor of Postoperative Pancreatic Fistula: Results from the LIPADRAIN study by Béranger Doussot, MD, Alexandre Doussot, MD, PhD, Ahmet Ayav, MD, PhD, Nicolas Santucci, MD, Sophie Deguelte, MD, Amadou Khalilou Sow, MD, Mehdi El Amrani, MD, PhD, Laurence Duvillard, MD, PhD, Guillaume Piessen, MD, PhD, Edouard Girard, MD, PhD, Jean-Yves Mabrut, MD, PhD, Jonathan Garnier, MD, PhD, Pablo Ortega-Deballon, MD, PhD, Isabelle Fournel, MD, PhD, Olivier Facy, MD, PhD

Get full text

Impact of acute respiratory distress syndrome on outcome in critically ill patients with liver cirrhosis by Pischtaz Adel Tariparast, Kevin Roedl, Thomas Horvatits, Andreas Drolz, Stefan Kluge, Valentin Fuhrmann

“…We observed a 28-day mortality or liver transplantation rate of 54% (n = 196) and 66% (n = 66%) in patients with MV and ARDS, respectively. …”
Get full text

Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary by Raymond Odhiambo, Jagpreet Chhatwal, Shannon Allen Ferrante, Antoine El Khoury, Elamin Elbasha

“…Estimates of probability of liver transplantation and cost were based on an analysis of the Hungarian Sick Fund database. …”
Get full text

Association between TyG-related indices and insulin resistance in cholelithiasis patients by Yu Shen, Xinyuan Wei, Shizheng Mi, Zhenhua Liu

Get full text